The FDA has approved Androderm (testosterone transdermal system; Watson) in 2mg and 4mg formulations. The smaller-sized and lower-dose patch reflects a 20% reduction in the active ingredient from the ...

PARSIPPANY, N.J. — The Food and Drug Administration has approved a new formulation of a testosterone therapy made by Watson Pharmaceuticals, the drug maker said Friday. Watson announced the approval ...

October 21, 2011 — The US Food and Drug Administration (FDA) has approved 2 lower-dose formulations of Watson Pharmaceutical's Androderm (testosterone transdermal system), the company announced today.

Testosterone transdermal patch is available as a brand-name drug. It’s not available as a generic drug. Brand name: Androderm. Testosterone comes in these forms: transdermal patch, topical gel, ...

May 28, 2004 -- A buccal testosterone delivery system is superior to the transdermal system, according to the results of a randomized trial published in the May issue of the Journal of Clinical ...